These results indicated that GSDMC assumed a vital function in modulating immune cell infiltration in BRCA, with specifically powerful influence on CD4+ T cells, CD8+ T cells, myeloid dendritic cells, and neutrophils. The gene discussed is CD4; the disease is invasive breast carcinoma.